Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Katz Website

Stephen I. Katz, M.D., Ph.D.

Selected Publications

1)  Villarroel VA, Okiyama N, Tsuji G, Linton JT, Katz SI.
CXCR3-Mediated Skin Homing of Autoreactive CD8 T Cells Is a Key Determinant in Murine Graft-Versus-Host Disease.
J. Invest. Dermatol. [Epub ahead of print], 2014.
2)  Okiyama N, Furumoto Y, Villarroel VA, Linton JT, Tsai WL, Gutermuth J, Ghoreschi K, Gadina M, O'Shea JJ, Katz SI.
Reversal of CD8 T-Cell-mediated mucocutaneous graft-versus-host-like disease by the JAK inhibitor tofacitinib.
J. Invest. Dermatol. 134: 992-1000, 2014.
3)  Katz SI.
Unity in action.
J. Invest. Dermatol. 134: 1184-6, 2014.
4)  Stingl G, Katz SI.
Wolfram Sterry: Physician - scientist - cosmopolitan.
J Dtsch Dermatol Ges. 12: 179-80, 2014.
5)  Miyagawa F, Okiyama N, Villarroel V, Katz SI.
Identification of CD3+CD4-CD8- T cells as potential regulatory cells in an experimental murine model of graft-versus-host skin disease (GVHD).
J. Invest. Dermatol. 133: 2538-45, 2013.
6)  Katz SI.
Hautarzt. 63 Suppl 1: 13, 2012.
7)  Miyagawa F, Zhang H, Terunuma A, Ozato K, Tagaya Y, Katz SI.
Interferon regulatory factor 8 integrates T-cell receptor and cytokine-signaling pathways and drives effector differentiation of CD8 T cells.
Proc. Natl. Acad. Sci. U.S.A. 109: 12123-8, 2012.
8)  Paek SY, Miyagawa F, Zhang H, Linton JT, Hoover SB, Simpson RM, Katz SI.
Soluble peptide treatment reverses CD8 T-cell-induced disease in a mouse model of spontaneous tissue-selective autoimmunity.
J. Invest. Dermatol. 132: 677-86, 2012.
9)  Chae JJ, Cho YH, Lee GS, Cheng J, Liu PP, Feigenbaum L, Katz SI, Kastner DL.
Gain-of-Function Pyrin Mutations Induce NLRP3 Protein-Independent Interleukin-1β Activation and Severe Autoinflammation in Mice.
Immunity. 34: 755-68, 2011.
10)  Paek SY, Steinberg SM, Katz SI.
Remission in Dermatitis Herpetiformis: A Cohort Study.
Arch Dermatol. 147: 301-5, 2011.
11)  Takeuchi S, Yasukawa F, Furue M, Katz SI.
Collared mice: a model to assess the effects of scratching.
J. Dermatol. Sci. 57: 44-50, 2010.
12)  Kárpáti SK, Katz SI.
Common goals and challenges in dermatological research in Eastern Europe.
J. Invest. Dermatol. 130: 1475-7, 2010.
13)  Katz SI.
The current status of investigative dermatology II.
Exp. Dermatol. 19: 857-9, 2010.
14)  Miyagawa F, Gutermuth J, Zhang H, Katz SI.
The use of mouse models to better understand mechanisms of autoimmunity and tolerance.
J. Autoimmun. 35: 192-8, 2010.
15)  Katz KA, Roseman JE, Roseman RL, Katz SI.
Dermatitis herpetiformis flare associated with use of triiodomethane packing strips for alveolar osteitis.
J. Am. Acad. Dermatol. 60: 352-3, 2009.
16)  Kim BS, Miyagawa F, Cho Y, Bennett CL, Clausen BE, Katz SI.
Keratinocytes Function as Accessory Cells for Presentation of Endogenous Antigen Expressed in the Epidermis.
J. Invest. Dermatol. 129: 2805-17, 2009.
17)  Katz SI.
Musculoskeletal research at the National Institute of Arthritis and Musculoskeletal and Skin Diseases: a snapshot.
J Bone Joint Surg Am. 91: 474-5, 2009.
18)  Gutermuth J, Nograles KE, Miyagawa F, Nelson E, Cho YH, Katz SI.
Self-peptides prolong survival in murine autoimmunity via reduced IL-2/IL-7-mediated STAT5 signaling, CD8 coreceptor, and Valpha2 down-regulation.
J. Immunol. 183: 3130-8, 2009.
19)  Katz SI.
Training at the NIAMS: ensuring a vibrant future for musculoskeletal research.
J Bone Joint Surg Am. 91: 2743-4, 2009.
20)  Marsh JL, McMaster W, Parvizi J, Katz SI, Spindler K.
AOA Symposium. Barriers (threats) to clinical research.
J Bone Joint Surg Am. 90: 1769-76, 2008.
21)  Miyagawa F, Tagaya Y, Kim BS, Patel HJ, Ishida K, Ohteki T, Waldmann TA, Katz SI.
IL-15 Serves as a Costimulator in Determining the Activity of Autoreactive CD8 T Cells in an Experimental Mouse Model of Graft-versus-Host-Like Disease.
J. Immunol. 181: 1109-19, 2008.
22)  Katz SI.
Irwin Freedberg and the government.
J Invest Dermatol. 126: 523, 2006.
23)  Alexander DF, Alving BM, Battey JF, Berg JM, Collins FS, Fauci AS, Gallin JI, Grady PA, Hodes RJ, Hrynkow SH, Insel TR, Jones JF, Katz SI, Landis SC, Li T, Lindberg DA, Nabel EG, Niederhuber JE, Pettigrew RI, Rodgers GP, Ruffin J, Scarpa A, Schwartz DA, Sieving PA, Straus SE, Tabak LA, Volkow ND.
Response to: "Rescuing the NIH before it is too late".
J Clin Invest. 116: 1462-3, 2006.
24)  Katz SI.
The national bone and joint decade: impact for rheumatic diseases.
Arthritis Rheum. 52: 707-9, 2005.
25)  Takeuchi S, Katz SI.
Use of interleukin 7 receptor-alpha knockout donor cells demonstrates the lymphoid independence of dendritic cells.
Blood. 107: 184-6, 2005.
26)  Katz SI.
Boning up for health: the national bone and joint decade.
J Bone Miner Res. 19: 1605-6, 2004.
27)  Shibaki A, Sato A, Vogel JC, Miyagawa F, Katz SI.
Induction of GVHD-like skin disease by passively transferred CD8(+) T-cell receptor transgenic T cells into keratin 14-ovalbumin transgenic mice.
J Invest Dermatol. 123: 109-15, 2004.
28)  Yamada N, Matsushima H, Tagaya Y, Shimada S, Katz SI.
Generation of a large number of connective tissue type mast cells by culture of murine fetal skin cells.
J Invest Dermatol. 121: 1425-32, 2003.
29)  Olasz EB, Lang L, Seidel J, Green MV, Eckelman WC, Katz SI.
Fluorine-18 labeled mouse bone marrow-derived dendritic cells can be detected in vivo by high resolution projection imaging.
J Immunol Methods. 260: 137-48, 2002.
30)  Shibaki A, Katz SI.
Induction of skewed Th1/Th2 T-cell differentiation via subcutaneous immunization with Freund's adjuvant.
Exp Dermatol. 11: 126-34, 2002.
31)  Olasz EB, Linton J, Katz SI.
Soluble proteins and haptens on bone marrow-derived dendritic cells are presented to host CD4 T cells in an MHC-restricted manner.
Int Immunol. 14: 493-502, 2002.
32)  Shibaki A, Katz SI.
Activation through CD40 ligation induces functional Fas ligand expression by Langerhans cells.
Eur J Immunol. 31: 3006-15, 2001.
33)  Gaspari AA, Katz SI.
Contact hypersensitivity.
Curr Protoc Immunol. Chapter 4: Unit 4.2, 2001.
34)  Katz SI.
Dermatological research in the 21st century: our fantastic future.
J Dermatol. 28: 599-601, 2001.
35)  Katz SI.
Dermatological research in the new millennium.
Clin Dermatol. 19: 51-3, 2001.
36)  Katz S.
Prospects for targeted gene therapy.
Clin Exp Dermatol. 25: 157, 2000.
Click Here to View Collapsed Bibliography.

This page was last updated on 5/2/2014.